Vagally Mediated Paroxysmal Atrial Fibrillation Derived from the Central Nervous System

Am J Med. 2018 Sep;131(9):e373-e374. doi: 10.1016/j.amjmed.2018.04.004. Epub 2018 May 3.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / physiopathology*
  • Humans
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology*
  • Tilt-Table Test

Substances

  • Antiparkinson Agents
  • Levodopa